ATGE
Company Description
Adtalem Global Education Inc. is a global enterprise dedicated to delivering comprehensive workforce and educational solutions. Established in 1987 and headquartered in Chicago, Illinois, the company was formerly known as DeVry Education Group Inc. until its name change in May 2017. The organization operates through three distinct segments: 1. Chamberlain: This division offers both academic degree programs and specialized non-degree coursework within the nursing and health professions postsecondary education sector, primarily facilitated by Chamberlain University. 2. Walden: Focused on online learning, the Walden segment provides a wide array of qualifications, from certificates and bachelor's degrees to master's and doctoral programs. These offerings, delivered via Walden University, span numerous fields including nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. 3. Medical and Veterinary: This segment is committed to postsecondary education in medical and veterinary sciences, furnishing students with both degree and non-degree program options. Its institutions include the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.79B | 1.58B | 1.45B | 1.38B | 899.25M | 866.43M | 1.24B | 1.23B | 1.81B | 1.84B | 1.91B | 1.92B |
| Net Income | 237.06M | 136.78M | 93.36M | 310.99M | 70.03M | (85.33M) | 128.77M | 33.77M | 122.28M | (3.17M) | 139.90M | 134.03M |
| EPS | 6.27 | 3.47 | 2.08 | -3.36 | 1.50 | 4.54 | 2.32 | 0.55 | 1.93 | -0.05 | 2.17 | 2.09 |
| Free Cash Flow | 287.57M | 246.88M | 165.90M | (20.45M) | 143.53M | 63.55M | 140.11M | 172.66M | 178.97M | 162.17M | 114.40M | 183.57M |
| FCF / Share | 7.75 | 6.26 | 3.70 | -0.42 | 2.80 | 1.18 | 2.39 | 2.81 | 2.82 | 2.53 | 1.77 | 2.86 |
| Operating CF | 337.90M | 295.77M | 191.91M | 10.60M | 192.20M | 107.69M | 204.86M | 239.19M | 227.96M | 231.57M | 203.11M | 262.92M |
| Total Assets | 2.75B | 2.74B | 2.81B | 3.03B | 3.03B | 2.23B | 2.24B | 2.34B | 2.32B | 2.10B | 2.04B | 2.00B |
| Total Debt | 774.00M | 847.85M | 896.19M | 1.07B | 1.07B | 516.79M | 401.09M | 293.07M | 125.00M | 0 | 0 | 0 |
| Cash & Equiv | 199.60M | 219.31M | 272.19M | 346.97M | 346.97M | 500.52M | 204.20M | 430.69M | 240.43M | 308.16M | 353.02M | 358.19M |
| Book Value | 1.43B | 1.37B | 1.46B | 1.49B | 1.49B | 1.31B | 1.39B | 1.52B | 1.67B | 1.58B | 1.58B | 1.53B |
| Return on Equity | 0.17 | 0.10 | 0.06 | 0.21 | 0.05 | -0.07 | 0.09 | 0.02 | 0.07 | -0.00 | 0.09 | 0.09 |
| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 487.03M | 503.38M | 462.29M | 457.11M | 466.06M | 447.73M | 417.40M | 409.91M | 412.66M | 393.24M | 368.85M | 364.64M |
| Net Income | 42.61M | 76.38M | 61.83M | 54.21M | 60.83M | 75.86M | 46.16M | 49.42M | 36.82M | 39.89M | 10.65M | 22.24M |
| EPS | 1.19 | 2.11 | 1.69 | 1.51 | 1.64 | 2.03 | 1.22 | 1.34 | 0.95 | 1.00 | 0.26 | 0.51 |
| Free Cash Flow | 165.89M | 15.12M | 114.53M | 40.70M | 197.67M | (29.70M) | 78.90M | 43.69M | 140.94M | (22.38M) | 78.90M | 35.54M |
| FCF / Share | 4.69 | 0.42 | 3.17 | 1.13 | 5.32 | -0.79 | 2.09 | 1.16 | 3.64 | -0.56 | 1.91 | 0.82 |
| Operating CF | 186.12M | 29.74M | 130.55M | 59.69M | 207.91M | (19.02M) | 89.32M | 40.57M | 153.64M | (7.10M) | 89.32M | 42.50M |
| Total Assets | 2.74B | 2.61B | 2.87B | 2.75B | 2.79B | 2.72B | 2.82B | 2.74B | 2.79B | 2.72B | 2.82B | 2.74B |
| Total Debt | 736.29M | 729.55M | 775.95M | 774.00M | 780.53M | 864.61M | 843.34M | 847.85M | 780.53M | 864.61M | 843.34M | 847.85M |
| Cash & Equiv | 146.98M | 56.28M | 264.69M | 199.60M | 219.02M | 193.96M | 264.80M | 219.31M | 219.02M | 193.96M | 264.80M | 219.31M |
| Book Value | 1.36B | 1.38B | 1.46B | 1.43B | 1.43B | 1.44B | 1.39B | 1.37B | 1.43B | 1.44B | 1.39B | 1.37B |
| Return on Equity | 0.03 | 0.06 | 0.04 | 0.04 | 0.04 | 0.05 | 0.03 | 0.04 | 0.03 | 0.03 | 0.01 | 0.02 |